May 6, 2024 · DOVATO is a fixed-dose combination tablet containing dolutegravir (as dolutegravir sodium), an integrase strand transfer inhibitor (INSTI), and lamivudine (also known as 3TC), a …

Dovato: Expiration Date, Partial Dispensing, Unit-Dose Repackaging, and Temperature Stability Summary • Once the original manufacturer’s bottle is opened and some tablets are partially …

Dovato is a once-daily, single-pill, 2-drug regimen (2DR) that combines the integrase strand transfer inhibitor (INSTI) dolutegravir with the nucleoside reverse transcriptase inhibitor (NRTI) …

View dosing & drug interactions for DOVATO (dolutegravir/lamivudine), an HIV-1 treatment for treatment-naïve and virologically suppressed adult patients. See full Indication, Boxed …

DOVATO (dolutegravir and lamivudine) is indicated as a complete regimen for the treatment of Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and adolescents 12 years of …

DOVATO is indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents above 12 years of age weighing at least 40 kg, with no known or …

Feb 6, 2024 · Dovato will continue to be available in a 30-pill bottle. Dovato is a once-daily, single-pill, two-drug combination of dolutegravir, an integrase strand transfer inhibitor (INSTI) and …

DOVATO is a fixed-dose tablet and should not be prescribed for patients requiring dosage adjustments, such as those with creatinine clearance less than 50 mL/min. DOVATO is not …

Mar 12, 2025 · Dovato is an HIV-1 treatment medication used for adults and adolescents 12 years and older, weighing at least 55 pounds (25kg). This antiviral medication offers a simplified …

Dovato is used to treat HIV in adults and adolescents over 12 years old who weigh at least 40 kg. Dovato does not cure HIV infection; it keeps the amount of virus in your body at a low level. …